Viatris has agreed to buy pain-drug maker Pacira BioSciences for $1.65 billion in a deal that expands the healthcare company’s medicines portfolio.
Source link
Greg WyshynskiOct 8, 2026, 08:41 AM ETCloseGreg Wyshynski is ESPN's senior NHL writer.Multiple AuthorsAs a service to fans who have a general interest in...
The price of oil jumped sharply Thursday, as President Donald Trump weighs whether to resume large-scale U.S. military operations against Iran in the coming...